ADAP
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
15.61M
64 days until earnings call
NEVPF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jan 23 closing price
Capitalization
45.13M
Interact to see
Advertisement

ADAP vs NEVPF

Header iconADAP vs NEVPF Comparison
Open Charts ADAP vs NEVPFBanner chart's image
Adaptimmune Therapeutics
Price$0.06
Change-$0.00 (-0.00%)
Volume$162.11K
Capitalization15.61M
Abliva AB
Price$0.03
Change-$0.00 (-0.00%)
Volume$58.9K
Capitalization45.13M
ADAP vs NEVPF Comparison Chart in %
Loading...
ADAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADAP vs. NEVPF commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADAP is a Hold and NEVPF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (ADAP: $0.06 vs. NEVPF: $0.03)
Brand notoriety: ADAP and NEVPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADAP: 94% vs. NEVPF: 100%
Market capitalization -- ADAP: $15.61M vs. NEVPF: $45.13M
ADAP [@Biotechnology] is valued at $15.61M. NEVPF’s [@Biotechnology] market capitalization is $45.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADAP’s FA Score shows that 0 FA rating(s) are green whileNEVPF’s FA Score has 0 green FA rating(s).

  • ADAP’s FA Score: 0 green, 5 red.
  • NEVPF’s FA Score: 0 green, 5 red.
According to our system of comparison, both ADAP and NEVPF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADAP’s TA Score shows that 5 TA indicator(s) are bullish.

  • ADAP’s TA Score: 5 bullish, 5 bearish.

Price Growth

ADAP (@Biotechnology) experienced а +3.51% price change this week, while NEVPF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

ADAP is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEVPF($45.1M) has a higher market cap than ADAP($15.6M). NEVPF YTD gains are higher at: -22.222 vs. ADAP (-89.066). NEVPF has higher annual earnings (EBITDA): -87.99M vs. ADAP (-149.75M). NEVPF has more cash in the bank: 32.7M vs. ADAP (26.1M). ADAP has higher revenues than NEVPF: ADAP (65.1M) vs NEVPF (0).
ADAPNEVPFADAP / NEVPF
Capitalization15.6M45.1M35%
EBITDA-149.75M-87.99M170%
Gain YTD-89.066-22.222401%
P/E RatioN/AN/A-
Revenue65.1M0-
Total Cash26.1M32.7M80%
Total Debt48.7MN/A-
FUNDAMENTALS RATINGS
ADAP vs NEVPF: Fundamental Ratings
ADAP
NEVPF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
89
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
9841
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a18

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ADAP's Valuation (47) in the Biotechnology industry is somewhat better than the same rating for NEVPF (89) in the null industry. This means that ADAP’s stock grew somewhat faster than NEVPF’s over the last 12 months.

ADAP's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as NEVPF (100) in the null industry. This means that ADAP’s stock grew similarly to NEVPF’s over the last 12 months.

NEVPF's SMR Rating (99) in the null industry is in the same range as ADAP (100) in the Biotechnology industry. This means that NEVPF’s stock grew similarly to ADAP’s over the last 12 months.

NEVPF's Price Growth Rating (41) in the null industry is somewhat better than the same rating for ADAP (98) in the Biotechnology industry. This means that NEVPF’s stock grew somewhat faster than ADAP’s over the last 12 months.

NEVPF's P/E Growth Rating (100) in the null industry is in the same range as ADAP (100) in the Biotechnology industry. This means that NEVPF’s stock grew similarly to ADAP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADAPNEVPF
RSI
ODDS (%)
Bullish Trend 5 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
84%
N/A
Momentum
ODDS (%)
Bearish Trend 7 days ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 5 days ago
85%
N/A
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
15%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
15%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
79%
N/A
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ADAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X109250.5900001013.875000
+0.94%
Bitcoin cryptocurrency
AAPL232.14-0.42
-0.18%
Apple
SPY645.05-3.87
-0.60%
SPDR® S&P 500® ETF
GME22.41-0.38
-1.67%
GameStop Corp
TSLA333.87-12.11
-3.50%
Tesla

ADAP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADAP has been loosely correlated with NEVPF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ADAP jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADAP
1D Price
Change %
ADAP100%
-14.51%
NEVPF - ADAP
56%
Loosely correlated
N/A
AKBA - ADAP
41%
Loosely correlated
+0.32%
CSLLY - ADAP
32%
Poorly correlated
+0.54%
OVID - ADAP
31%
Poorly correlated
+2.40%
ATXS - ADAP
30%
Poorly correlated
-5.36%
More

NEVPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEVPF has been loosely correlated with CELC. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if NEVPF jumps, then CELC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEVPF
1D Price
Change %
NEVPF100%
N/A
CELC - NEVPF
61%
Loosely correlated
-6.17%
ADAP - NEVPF
56%
Loosely correlated
-14.51%
YMAB - NEVPF
56%
Loosely correlated
+0.12%
VYNE - NEVPF
52%
Loosely correlated
-2.73%
PMN - NEVPF
49%
Loosely correlated
+2.74%
More